ACXP - Company ID 0001736243
Acurx Pharmaceuticals, Inc. trades as ACXP. This page tracks Acurx Pharmaceuticals, Inc. through 232 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| 424B3 | - | 2026-05-12 |
| 424B3 | - | 2026-05-12 |
| EFFECT | - | 2026-05-11 |
| EFFECT | - | 2026-05-11 |
| Quarterly report | 10-Q | 2026-05-11 |
| IPO registration | S-1 | 2026-05-04 |
| IPO registration | S-1 | 2026-05-04 |
| D | - | 2026-04-29 |
The largest companies sharing Acurx Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Acurx Pharmaceuticals, Inc. reported a net loss of $7.97M.